HIV Treatment Adherence Dose Determination Trial
ConditionHIV Infections
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Connecticut
About this trial
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Eligibility criteria
Qualifiers
Confirmed HIV positive
Confirmed prescribed antiretroviral therapy
Confirmed non-adherent to anti-retroviral therapy
Disqualifiers
Does not have access to a phone
Does not have access to the internet
Trial design
Treatments tested in this trial
- Behavioral Self-Regulation Adherence Counseling
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Connecticut
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov